NSEAnalysts/Institutional Investor Meet/Con. Call Updates25 Jul 2026 · 25 Jul 2026, 03:02 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Onesource Specialty Pharma Limited · ONESOURCE

✦ AI SummaryResults

OneSource Specialty Pharma Limited has informed the Exchange about the link of the recording of their earnings call for the unaudited financial results for the quarter ended June 30, 2026. The recording is available on their website.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

OneSource Specialty Pharma Limited has informed the Exchange about Link of Recording

Attachments (1)

📄

ONESOURCECDMO_25072026150106_Intimation_of_Audio_Recording_of_Earnings_call.pdf

pdf

Download →
View document text
Corporate Office: Registered Office: Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi, Navi Mumbai 560076, India 400703 India T: +91 80 6784 0738 F: +91 22 2789 2924 T: 91 22 2789 2942 Date: July 25, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Scrip Code: 544292 Symbol: ONESOURCE Dear Sir/ Madam, Subject: Intimation of Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter ended June 30, 2026 Pursuant to Regulation 46 & 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we wish to inform you that the audio recording of Earnings Call held today i.e., July 25, 2026 at 10:00 hrs (IST) for discussing unaudited financial results of the Company for the quarter ended June 30, 2026, has been made available on our Company’s website at: https://www.onesourcecdmo.com/wp-content/uploads/2026/07/Earning_Call_Audio_Recording_for_Q1_FY27.mp3 You are requested to kindly take the same on record. For and on behalf of OneSource Specialty Pharma Limited Trisha A Company Secretary and Compliance Officer Membership Number: A47635 OneSource Specialty Pharma Limited Formerly Stelis Biopharma Limited info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497